Clinical Trial Update: CBD Cannabis Extract: Pharmacokinetic Studies [EARLY_Phase 1]

View source ↗

Summary

This early Phase 1 pharmacokinetic study of CBD cannabis extract in individuals with epilepsy has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• CBD cannabis extract (cannabidiol)

Snippet

Sponsor: University of Mississippi, Oxford | Conditions: Epilepsy | EARLY_Phase 1 | Status: COMPLETED